Erythromycin oxime
- Level
- Commodity
- Parent
- 51282300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282323This classification denotes a macrolide antibiotic C37H68N2O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 10W452CMTZ, chemically known as erythromycin, 9-oxime, but more generally known as erythromycin oxime, which bears US NIH Compound Identifier 6537896. Most nations, for tariff and trade purposes, schedule erythromycin oxime under HS 29415000 and SITC 54139. As of Q4 2014, ERYTHROMYCIN OXIME remains US FDA's Preferred Term for this commodity. Erythromycin oxime bears US NLM identifiers UMLS ID C0207096 and NCI Concept Code C87758. SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=NO)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.
Same parent
Under 51282300 · 28Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.